For the quarter ending 2026-03-28, SMG had -$2,200K decrease in cash & cash equivalents over the period. $201,400K in free cash flow.
| Cash Flow | 2026-03-28 | 2025-12-27 | 2025-09-30 | 2025-06-28 |
|---|---|---|---|---|
| Net income from continuing operations | 215,600 | - | - | - |
| Loss from discontinued operations, net of tax | -102,000 | - | - | - |
| Net income (loss) | - | - | 145,200 | - |
| Net income | 238,600 | -422,100 | - | 297,100 |
| Impairment, restructuring and other | 200 | 600 | 5,700 | 16,000 |
| Share-based compensation expense | 18,900 | 7,400 | 13,400 | 55,600 |
| Depreciation | 15,400 | 15,600 | 15,600 | 47,100 |
| Amortization | 700 | 2,800 | 2,900 | 9,400 |
| Deferred taxes | -6,900 | -22,900 | -5,700 | 76,500 |
| Loss on sale of business | - | - | -17,700 | - |
| Loss on measurement of held for sale assets | -29,600 | -104,800 | - | - |
| Equity in loss of unconsolidated affiliates | -4,500 | -13,100 | -12,300 | 9,500 |
| Accounts receivable | 573,600 | 30,300 | -378,600 | 395,200 |
| Inventories | -150,400 | 300,900 | 60,400 | -42,500 |
| Prepaid and other current assets | -22,300 | 27,700 | 14,900 | -12,600 |
| Accounts payable | 98,200 | 63,100 | -15,000 | 14,700 |
| Other current liabilities | 215,100 | -82,500 | -22,700 | 38,700 |
| Other non-current items | -5,100 | -15,800 | 3,100 | 6,100 |
| Other, net | -1,500 | 4,300 | -1,600 | 2,200 |
| Net cash used in operating activities | 220,000 | -370,400 | 174,100 | 197,200 |
| Investments in property, plant and equipment | 18,600 | 20,000 | 42,900 | 54,500 |
| Investments in loans receivable | - | - | 8,500 | - |
| Proceeds from loans receivable | - | - | 0 | - |
| Investments in unconsolidated affiliates | - | - | 0 | 0 |
| Net cash disposed of on sale of business | - | - | 2,500 | - |
| Other investing, net | 5,000 | 1,800 | -1,800 | 5,500 |
| Net cash used in investing activities | -23,600 | -21,800 | -52,100 | -60,000 |
| Borrowings under revolving and bank lines of credit and term loans | 34,300 | 1,145,600 | 7,100 | 695,600 |
| Repayments under revolving and bank lines of credit and term loans | 215,800 | 723,100 | 89,900 | 734,900 |
| Financing and issuance fees | 100 | 8,600 | - | - |
| Dividends paid | 39,500 | 38,300 | 38,100 | 116,200 |
| Purchase of common shares | 3,300 | 8,300 | 0 | 18,400 |
| Cash received from exercise of stock options | 2,600 | 700 | 700 | 11,200 |
| Other financing, net | 23,200 | -1,200 | -15,600 | 4,500 |
| Net cash provided by financing activities | -198,600 | 366,800 | -135,800 | -158,200 |
| Effect of exchange rate changes on cash | 0 | 100 | -700 | 500 |
| Net decrease in cash and cash equivalents | -2,200 | -25,300 | -14,500 | -20,500 |
| Cash and cash equivalents at beginning of period | 32,800 | - | 71,600 | - |
| Cash and cash equivalents at end of period | 6,200 | - | 36,600 | - |
SCOTTS MIRACLE-GRO CO (SMG)
SCOTTS MIRACLE-GRO CO (SMG)